BRENTUXIMAB VEDOTIN
Clinical trials for BRENTUXIMAB VEDOTIN explained in plain language.
Never miss a new study
Get alerted when new BRENTUXIMAB VEDOTIN trials appear
Sign up with your email to follow new studies for BRENTUXIMAB VEDOTIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare lymphoma: drug combo targets tough-to-treat cancer
Disease control Not yet recruitingThis study tests whether adding brentuximab vedotin to standard chemotherapy (R-CHP) works better for people newly diagnosed with a rare, aggressive lymphoma linked to the Epstein-Barr virus. About 25 adults will receive the combination and be followed for 2 years to see if the c…
Matched conditions: BRENTUXIMAB VEDOTIN
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 17, 2026 13:01 UTC
-
New hope for skin lymphoma: drug after transplant may keep cancer away
Disease control Not yet recruitingThis study tests whether giving brentuximab vedotin (a targeted drug) right after a stem cell transplant can prevent early relapse in people with advanced cutaneous T-cell lymphoma (CTCL). About 84 adults aged 18–70 with CD30-positive mycosis fungoides who have already tried at l…
Matched conditions: BRENTUXIMAB VEDOTIN
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 12:58 UTC